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Abstract
A chromatographic immunoassay is a technique in which an antibody or 
antibodyrelated agent is used as part of a chromatographic system for 
the isolation or measurement of a specific target. Various binding agents, 
detection methods, supports and assay formats have been developed for 
this group of methods, and applications have been reported that range 
from drugs, hormones and herbicides to peptides, proteins and bacte-
ria. This review discusses the general principles and applications of chro-
matographic immunoassays, with an emphasis being given to methods 
and formats that have been developed for the analysis of drugs and bi-
ological agents. The relative advantages or limitations of each format 
are discussed. Recent developments and research in this field, as well as 
possible future directions, are also considered.   
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Key terms 
 
Chromatographic immunoassay: A technique in which an antibody or antibody-
related agent is attached to a support and used as part of a chromatographic 
system for the isolation or measurement of a specific target; also known as 
an immunochromatographic assay, a flow immunoassay or a flow-injection 
immunoassay.   
Direct detection chromatographic immunoassay: A chromatographic immuno-
assay that is used for direct detection of a target.  
Immunoextraction: The use of immobilized antibodies to isolate a given target 
prior to its analysis or measurement by a second method.   
Simultaneous injection method: A type of competitive binding chromatographic 
immunoassay in which a sample is mixed with a fixed amount of the label and 
applied together to a column containing a limited amount of an immobilized 
antibody or related binding agent for the target.  
Sequential injection method: A type of competitive binding chromatographic im-
munoassay in which the sample is applied first to a column containing an im-
mobilized antibody or related binding agent, followed later by application of 
the label.  
Displacement immunoassay: A type of chromatographic immunoassay in which 
a target displaces a label from a column containing an immobilized antibody or 
related binding agent.   
One-site immunometric assay: A type of chromatographic immunoassay in which 
a sample containing the target is incubated with an excess of labeled antibod-
ies (or related binding agents) that can bind to this target, followed by injec-
tion of this mixture onto a column that contains an immobilized analog of the 
target.  
Chromatographic sandwich immunoassay: A type of chromatographic immuno-
assay that employs two types of antibodies or binding agents that can bind si-
multaneously to the same target; one type of binding agent is immobilized to 
a support, and the second binding agent is labeled and mixed with the sample 
before these components are applied to the column or applied to the column 
after the sample has been injected.  
 
The analysis of drugs and biological compounds is an essential 
component in clinical chemistry, therapeutic drug monitoring, pro-
teomics and the screening or development of new pharmaceutical 
agents [1,2]. Common challenges that are often faced in these fields 
are the complexity of the samples that are being examined and the 
low concentrations of the desired compounds that must be mea-
sured. One way to overcome these challenges is to utilize immuno-
assays, which can often provide sensitive and specific measurements 
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for drugs and other compounds in complex samples [1–5]. An immu-
noassay can be defined as an analytical technique that utilizes anti-
bodies or antibody-related agents to selectively bind a given target 
compound [3–5]. Antibodies are glycoproteins that are produced by 
the immune system in response to a foreign agent, or antigen [2,3]. 
Antibodies can be generated against a wide range of compounds and 
can have both specific and strong binding, with many antibody–target 
interactions having association equilibrium constants in the range of 
105 to 1012 M-1. These interactions are reversible and usually involve a 
combination of steric effects and noncovalent forces such as dipole-
related interactions, ionic forces, nonpolar interactions and hydrogen 
bonding [6].  
Antibodies have been used in many formats to carry out immu-
noassays. One method that has been of interest in recent years is a 
chromatographic immunoassay or immunochromatographic assay 
(also sometimes called a ‘flow immunoassay’ or ‘flowinjection immu-
noassay’) [5–13]. In this technique, an antibody or antibody-related 
agent (e.g., an antibody fragment) is attached to a chromatographic 
support or used as part of a chromatographic system for the isola-
tion or measurement of a specific target. A simple example of such a 
method is shown in Figure 1 [14]. Various binding agents, detection 
methods, supports and assay formats have been reported for this 
group of methods. In addition, this set of techniques has been used 
in applications ranging from low mass compounds such as drugs, hor-
mones and herbicides to higher mass targets such as peptides, pro-
teins and bacteria [6–14].  
This review will discuss the general principles, components and 
applications of chromatographic immunoassays. Particular emphasis 
will be given to methods that have been developed for the analysis of 
drugs and biological agents. This discussion will include an overview 
of the types of binding agents, detection methods, supports and elu-
tion conditions that can be used in this approach. This will be followed 
by a description of the various measurement formats that have been 
reported for chromatographic immunoassays. Representative appli-
cations for each format will be presented, and the relative advantages 
or limitations of each format will be examined. Recent developments 
and research in this field, as well as possible future directions in this 
area, will also be considered.  
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General components of chromatographic immunoassays  
 
Antibodies & related binding agents  
 
The antibody or binding agent that is used in a chromatographic 
immunoassay is usually the key factor in determining the specific-
ity for this type of method [6,7]. A typical IgG class antibody, as used 
within the scheme shown in Figure 1A, has a ‘Y’-shaped structure 
that is composed of four polypeptide chains (i.e., two identical sets 
of heavy and light chains) which are linked by disulfide bonds [3,6]. 
The Fc region (i.e., the ‘crystallizable fragment’ or ‘constant region’) is 
located in the lower stem region of this structure and is highly con-
served from one antibody to the next in the same class. Two identi-
cal Fab regions (or ‘antigen binding’ regions) are found in the upper 
portion of the antibody and contain the sites at which a given target, 
or ‘antigen,’ can bind to the antibody. A change in the amino acid se-
quence within the Fab regions from one type of antibody to the next 
is what makes it possible for the body to produce antibodies against 
a wide variety of foreign agents [6,8].  
Many chromatographic immunoassays utilize intact polyclonal an-
tibodies or monoclonal antibodies. Polyclonal antibodies are the typ-
ical antibodies that are produced by the immune system. This type of 
preparation often consists of a heterogeneous population of antibod-
ies with a range of affinities and binding regions on a particular anti-
gen or target. This type of antibody is often used when strong bind-
ing is required in an immunoassay and when some cross-reactivity of 
the antibodies with agents that are closely related to the target is ei-
ther desired or acceptable [6,7]. Monoclonal antibodies are produced 
from single hybrid cell lines, or ‘hybridomas,’ and are used when an-
tibodies with a high level of specificity and good batch-to-batch re-
producibility are needed [6–8]. Other types of antibodies that have 
been used occasionally in chromatographic immunoassays are auto-
antibodies, which are naturally occurring antibodies produced against 
components of the original host, and anti-idiotypic antibodies, which 
bind to receptors or their substrates in the body [6]. In addition, anti-
body fragments, such as those consisting of the Fab portion of an an-
tibody, can be used as binding agents in some types of chromato-
graphic immunoassays [6,7].  
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Figure 1. Direct detection format for a chromatographic immunoassay. (A) General 
scheme for a chromatographic immunoassay with direct detection of its target(s) 
and (B) use of a low-performance 150 mm × 10.0 mm id antibody column for the 
immunoextraction of d-methamphetamine and related compounds from urine, fol-
lowed by analysis of these extracted solutes by GC–MS. The fractions in (B) each a 
volume of 0.6 ml and were collected at 0.4 ml/min; the contents of these fractions 
were then derivatized with trichloroanhydride and placed into ethyl acetate prior 
to injection onto a GC–MS system. The results in (B) are for the analysis of normal 
urine (circles) or urine (triangles) from a methamphetamine addict; the inset shows 
the pH gradient that was used for elution of the retained target from the antibody 
column.  (B) Adapted with permission from [14].   
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There has been additional work involving the use of genetically 
engineered antibodies or antibody-like molecules in chromato-
graphic immunoassays [6]. The use of these binding agents can pro-
vide greater versatility than traditional antibodies in the categories 
of compounds that can be analyzed by a chromatographic immuno-
assay and may even lead to an improvement in the binding strength 
and specificity for a target [6,15]. In some cases, these agents can be 
created to be ‘bifunctional’ or ‘bispecific,’ which allows their interac-
tion with two different antigens or targets at the same time [6]. A few 
studies have also explored the use of recombinant single-chain anti-
body fragments for use in the chromatographic purification of pro-
teins from cell cultures and cell lysates [6,16].  
Aptamers have been used as ‘antibody mimics’ or alternatives to 
antibodies in some chromatographic binding assays [17–20]. These 
binding agents consist of single-stranded DNA or RNA sequences 
that are often 10 to 100 nucleotides in length and that have the abil-
ity to form highly ordered 3D structures [19]. Aptamers are prepared 
through a selection and amplification process known as SELEX (i.e., the 
‘systematic evolution of ligands by exponential enrichment’), which 
can be used to generate specific binding agents with relatively high 
affinities for a particular target [17,18]. These agents have been used 
to bind targets that have included drugs, peptides, proteins and cells 
[17–20]. It is possible to easily modify the structure of an aptamer to 
include a label or to immobilize the aptamer to a support [18,19]. In 
addition to being used in biosensors [17,18], aptamers have been em-
ployed in chromatography for both the purification of proteins [20] 
and in various forms of chromatographic binding assays [19].  
A molecularly imprinted polymer (MIP) is another type of binding 
agent that can be used as an alternative to antibodies [21–25]. A MIP 
is a synthetic polymer that is prepared to have recognition sites for 
a given target. This type of material is produced through a polymer-
ization reaction which makes use of one or more functional mono-
mers, a cross-linking agent and a template, with the latter being the 
target of interest or a compound that is related in structure to the 
target [21–23]. A common scheme for preparing a MIP, or for ‘mo-
lecular imprinting,’ is shown in Figure 2. During this procedure, the 
functional monomers are allowed to interact with complementary re-
gions on the template. These monomers are then set in place by re-
acting them with a cross-linking agent. The result is a highly ordered 
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polymer that contains cavities and functional groups that are com-
plementary to the size, shape and structure of the template. The tem-
plate is then removed, leaving behind a specific binding site that can 
later be used to extract or retain the same template or desired target 
from a sample [21–24]. Although MIPs are based on a polymeric net-
work rather than a biological agent, it has been found that MIPs can 
be generated with specificities and affinities that are similar to those 
of antibodies [25]. These features have made MIPs of interest as bind-
ing agents in biosensors, traditional immunoassays and extractions 
[21–25], as well as in some types of chromatographic methods [21,25]. 
 
 
Detection methods in chromatographic immunoassays  
 
Chromatographic immunoassays can be used with a variety of de-
tection methods. Common examples are absorbance and fluorescence 
detection, with chemiluminescence, electrochemical detection, radio-
metric detection, thermal measurements and MS also having been 
employed [7,8,10]. Many of these detection methods require the use 
of an antibody or target analog that contains a chemical label or 
Figure 2. An example of a procedure for the creation of a MIP against a given tar-
get [21–23].  MIP: Molecularly imprinted polymer.   
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enzymatic tag. However, some of these methods make use of the in-
herent properties of the target for its direct detection [7,10].  
This latter situation often occurs in the case of absorbance detec-
tion. This method works best for targets that can absorb light in the 
UV or visible range and that have moderate or relatively high concen-
trations in the sample. Typical detection limits for this approach are 
in the 10-8 to 10-7 M range when used for direct target detection, with 
some applications even reaching levels of 10-9 M [8]. Lower detection 
limits can also be obtained with absorbance detection when this is 
combined with enzyme labels that can generate products which will 
absorb UV or visible light [8,10,12].  
Fluorescence detection can be used with analytes that are natu-
rally fluorescent or with analogs of these targets that contain a fluo-
rescent tag. Examples of fluorescent tags that have been used in chro-
matographic immunoassays are fluorescein, Texas red, Cascade blue 
and Lucifer yellow [8]. A major advantage of fluorescence over absor-
bance is that it is capable of providing much more selective detection 
and lower detection limits. The limit of detection when using tradi-
tional fluorescent tags on a target or labeled compound is often in 
the range of 10-9 to 10-11 M [7,8]. Even lower detection limits are again 
possible when fluorescence detection is combined with an enzyme 
label [8]. Near infrared fluorescent tags have also been employed in 
chromatographic immunoassays [26–28], resulting in detection lim-
its as low as 10-10 to 10-13 M [26,27].  
Two other detection methods that usually require the use of a label 
are those based on chemiluminescence or radioisotopes. Chemilumi-
nescence makes use of a label or reagent that is capable of produc-
ing light as a result of a chemical reaction [7,8,29,30]. Two examples of 
chemiluminescent tags are acridinium ester and derivatives of luminol 
[8]. Advantages of this detection method are the low background re-
sponse and ease with which small amounts of light can be measured, 
which can provide detection limits down to 10-12 to 10-13 M [7,29,30]. 
Radiolabels such as iodine-125 have been used for detection in a few 
chromatographic immunoassays for targets such as methotrexate and 
2,4-dinitrophenol, with detection limits ranging from 10-7 to 10-9 M 
[8,31]. However, this detection approach has several potential disad-
vantages. These disadvantages include safety issues that are associ-
ated with the handling of radiolabels and the limited stability of ra-
diolabels over extended periods of time [8,10].  
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MS, thermometric analysis and electrochemical detection have 
also been employed in chromatographic immunoassays. MS has been 
combined with both on-line and off-line chromatographic immunoas-
says and has been used for the analysis of a variety of targets [6,9,32]. 
Thermometric detection has been used with enzyme labels to mea-
sure the heat that is produced by an enzymatic reaction [7,8]. The lim-
its of detection that have been obtained in chromatographic immu-
noassays based on thermometric detection have ranged from 10-8 to 
10-10 M [7,8,33]. Electrochemical detection has been used with enzyme 
labels and chromatographic immunoassays to measure the change 
in current that occurs upon the oxidation or reduction reaction of an 
electrochemically active product. This combination has provided lim-
its of detection ranging from 10-7 to 10-11 M [7,8].  
In chromatographic immunoassays that use enzyme labels, the en-
zyme tag is combined with a substrate to produce an enzymatic prod-
uct, which is then measured [8,10]. A major advantage of using an en-
zyme label is its ability to act as a catalyst and produce many copies 
of the product, which results in signal amplification [8]. The enzymes 
that are most often utilized as labels in chromatographic immunoas-
says are β-galactosidase, alkaline phosphatase and horseradish per-
oxidase. Other enzymes that have been used in these assays are cat-
alase, glucose oxidase and adenosine deaminase. The products of 
these enzymes have been measured through the use of light absorp-
tion, fluorescence, chemiluminescence, electrochemical detection and 
thermometric analysis [8].  
Liposomes have also been employed as labels in chromatographic 
immunoassays [7,8]. In this case, the liposome label is composed of 
phospholipids that have been coupled with either an antibody or 
antigen; the liposome also contains many copies of a water soluble 
marker (e.g., a fluorescent compound). During the detection phase 
of the chromatographic immunoassay, the structure of the liposome 
is disrupted through the addition of a detergent or by using shear 
force to release markers within the liposome for detection. This pro-
cess can lead to a large signal, as each liposome may contain up to 
103 copies of the marker compound. Liposome labels have been used 
in chromatographic immunoassays for the detection of various tar-
gets, such as caffeine, theophylline, antitheophylline, imazethapyr and 
17-estradiol [8].  
 
 
M a t s u d a  e t  a l .  i n  B i o a n a l y s i s  7  ( 2 0 1 5 )       10
Supports, immobilization methods & elution conditions  
 
Another important component of a chromatographic immunoas-
say is the support that contains the immobilized antibody or anti-
body-related agent. The type of support that is used will be deter-
mined by the overall goal of the assay. For example, supports that are 
to be employed in offline or manual methods and that do not require 
high efficiency are often based on large and relatively nonrigid mate-
rials such as agarose or cellulose. Other supports that are sometimes 
used in these methods are organic polymers such as polyacrylamide, 
polymethacrylate, polyethersulfone and related derivatives [6,7]. These 
materials are often inexpensive and easy to use at low back pressures; 
however, they tend to have slow mass transfer properties and can be 
difficult to use in automated systems, such as those utilized in HPLC. 
Most of these materials are used in packed columns for chromato-
graphic immunoassays [6–8,10,13], but it is also possible to use low-
performance supports to carry out chromatographic immunoassays 
in planar systems, as occurs in lateral flow immunoassays [19]. A typ-
ical system for this latter method is shown in Figure 3A. Nitrocellulose 
is a common support that is employed in these planar methods [19]. 
Supports are also available for chromatographic immunoassays 
that can be used in HPLC systems. An example of such a system is 
provided in Figure 3B. The supports that are used in these systems 
are often more expensive, smaller in size and have greater mechanical 
stability than those that are used in low-performance or planar sys-
tems. Examples of supports that can be used with HPLC include small 
diameter silica or porous glass beads, perfusion supports and some 
types of monolithic materials [6–8]. The advantages of using these 
materials with HPLC to carry out chromatographic immunoassays in-
clude the ease with which such systems can be automated, the abil-
ity to couple these methods on-line with other analytical techniques 
(e.g., MS or other forms of HPLC), and the speed and precision of the 
resulting assays [6–8,10,12,13].  
The method of attachment for the immobilized agent in a chro-
matographic immunoassay is another important factor to consider 
[6,8]. This process often involves covalent immobilization. This type 
of immobilization can be conducted by reacting free amine groups 
on an antibody or related binding agent with a support that has been 
activated with chemicals such as N,N’-carbonyl diimidazole, cyanogen 
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bromide, N-hydroxy succinimide or tresyl chloride/tosyl chloride 
[6,8,34,35]. Activated supports with oxidized functional groups, such 
as aldehydes or epoxy groups, can also be utilized to immobilize these 
binding agents through their free amine groups [6,7]. In an alterna-
tive approach, carbohydrate groups found in the Fc regions of anti-
bodies can be oxidized and used for the site directed immobilization 
of antibodies onto supports that contain hydrazide or amine groups 
[34,35]. In addition, Fab fragments can be coupled through their free 
sulfhydryl groups with thiol-reactive supports [6,34,35].  
Antibodies or binding agents such as aptamers can also be immo-
bilized through the use of secondary binding agents [6,7,19]. For in-
stance, this may involve the biotinylation of antibodies or aptamers, 
followed by the biospecific coupling of these agents to supports that 
contain immobilized streptavidin or avidin [19,35]. Another option 
Figure 3. Examples of chromatographic immunoassays using low- or high-perfor-
mance supports. (A) General scheme for the use of a chromatographic immunoas-
say in a planar system, such as a lateral flow immunoassay [19] and (B) an exam-
ple of an HPLC system for conducting a chromatographic sandwich immunoassay, 
as based on the use of a postcolumn reactor for chemiluminescent detection. The 
system in (B) is based on a method that was reported in [29].   
M a t s u d a  e t  a l .  i n  B i o a n a l y s i s  7  ( 2 0 1 5 )       12
for antibodies is to adsorb them to supports that contain immobi-
lized immunoglobulin binding agents such as protein A or protein G. 
These latter agents bind to the Fc regions in many types of antibodies 
and can allow for the site-specific but reversible coupling of an an-
tibody to a chromatographic support [6–8,13,35]. If desired, the ad-
sorbed antibodies can later be released from the protein A or protein 
G by lowering the pH of the mobile phase. The protein A or G sup-
port can then be regenerated prior to the application of a fresh por-
tion of antibodies [7,10,13].  
The application of a sample or assay components in a chromato-
graphic immunoassay is usually conducted through the use of a buf-
fer that allows for strong and efficient binding. In most cases, physio-
logical conditions (e.g., a pH of 7.0–7.4) are utilized to allow optimum 
binding to occur between the antibody or binding agent and its tar-
get [6–8]. Typical elution conditions that are used to later dissociate 
an antibody from its target might involve lowering the pH of the mo-
bile phase or changing the composition of this mobile phase, such as 
through the addition of a chaotropic agent (e.g., thiocyanate, trifluo-
roacetate, iodide or chloride) [6–8,12]. If the support or column is to 
be used for multiple assays, as is usually the case in HPLC based ap-
plications, care must be taken to select elution conditions that do not 
cause irreversible damage to the immobilized antibodies or binding 
agents within the column [6,36]. It is also necessary in this situation 
to allow sufficient time for the column to regenerate prior to applica-
tion of the next sample [36].  
 
 
Chromatographic immunoassays with direct target detection  
 
For some types of targets and samples it is possible to use chro-
matographic immunoassays with a ‘nonlabel’ format and direct de-
tection of the target [6–8]. This type of direct detection chromato-
graphic immunoassay is usually carried out by using step or gradient 
elution, as is represented in Figure 1 [6,7,11]. In this method, a sam-
ple is first applied to a column containing immobilized antibodies 
or related agents that can bind to some components in the sample. 
This application is carried out under conditions in which the column 
can selectively retain its target, while other components of the sam-
ple tend to wash through the column. An elution buffer is later used 
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to release the target from the column for its detection or for use in 
a second analytical method. Once the target has been removed, the 
column may then be regenerated before the application of the next 
sample [6–8,10].  
The specificity and response of a chromatographic immunoassay 
with direct detection will depend on the nature of the target and its 
interaction with the immobilized antibodies or binding agents [8]. 
In this format, it is usually desirable to have relatively strong binding 
of the target with the immobilized binding agents so that this com-
pound can be effectively retained by the column during the sample 
application step. However, it should also be possible to later release 
the target, such as by changing the pH, polarity or composition of 
the buffer that is passing through the column [6,8]. The immobi-
lized binding agents should also be sufficiently selective for the tar-
get to avoid giving a response that might be due to other sample 
components [7,8].  
The relative response of a chromatographic immunoassay with di-
rect detection will tend to increase as the amount of target in the sam-
ple increases [7,8,10,37,38]. One factor that will determine the usable 
range of this response is the amount of active binding agent that is 
present in the column [8]. For instance, as the amount of the applied 
target is increased, the binding sites in the column will eventually be-
come saturated and will no longer provide a change in response as 
the amount of the target is increased further. The application flow rate 
can also affect this response, where low flow rates will tend to pro-
vide a better capture efficiency and lower detection limit for the tar-
get, while higher flow rates will give a lower capture efficiency but a 
broader dynamic range [8]. Another interesting feature for this type of 
assay is that the response is generally dependent on the moles of the 
applied target rather than on its initial concentration [8,37]. A prac-
tical consequence of this feature is that adjustments can be made to 
the volume of sample that is applied to the column in order to adjust 
the calibration range for the target to lower concentration-based lim-
its of detection. This effect has been demonstrated with a multicol-
umn chromatographic immunoassay system for atrazine and its deg-
radation products, where an increase in the applied sample volume 
from 0.4 to 3.0 ml resulted in a steeper slope for the calibration plot 
and a decrease in the concentration- based detection limit of atrazine 
from 170 to 20 ng/l [37].  
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There have been several reports that have made use of direct de-
tection in chromatographic immunoassays. These applications have 
utilized detection based on light absorption, fluorescence, chemilu-
minescence or MS [7,10,38–47]. This method has been used for large 
targets such as proteins, peptides and carbohydrates [7]. For instance, 
one report utilized this format in a dual-column HPLC system for the 
simultaneous analysis of human serum albumin (HSA) and IgG in se-
rum [38]. Other applications have utilized the direct detection for-
mat in clinical tests for bacteria such as Escherichia coli and meth-
icillin-resistant Staphylococcus aureus [39,40]. This format has also 
been employed for the analysis of various low mass targets, includ-
ing drugs, herbicides, toxins and synthetic dyes [7,9,41–45]. A recent 
report used chemiluminescent detection to directly measure bovine 
serum albumin that had been selectively adsorbed to columns packed 
with molecularly imprinted microspheres [46]. A related system has 
been utilized with magnetic oil-based surface molecularly imprinted 
nanoparticles for the analysis of bisphenol A [47].  
Although the use of direct detection in a chromatographic immu-
noassay has the advantages of speed and simplicity, there are sev-
eral possible disadvantages for this format. First, the target must have 
some inherent signal that can be measured (e.g., absorbance or fluo-
rescence), and the target needs to be present in a sample at a concen-
tration that will provide a measurable signal [8,10]. This requirement 
tends to limit the use of direct detection in chromatographic immu-
noassays to major sample components or those with moderate con-
centrations. As a result, this method is usually not suitable for trace 
analysis unless it is used with large sample volumes [8,37]. In these sit-
uations, an alternative would be to use a chromatographic immunoas-
say based on indirect detection (e.g., a competitive binding immuno-
assay or immunometric assay), as will be discussed later in this review. 
Another way to enhance the capabilities of a chromatographic im-
munoassay with direct detection is to couple this format with other 
analytical techniques. When immobilized antibodies are used to iso-
late a target prior to its measurement or analysis by a second method, 
this approach is often referred to as immunoextraction [7,8]. This may 
be carried out by using columns that are prepared in-house, or by us-
ing one of the growing number of columns that are available com-
mercially for this type of work [48–52]. In many cases, the column that 
is used for immunoextraction can be placed on-line with the second 
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analysis method, as has been used with various forms of HPLC, MS 
and CE [8,9,12,32]. Analytical methods can also be combined off-line 
with immunoextraction, as is commonly used in coupling this tech-
nique with GC or GC–MS [7]. For instance, the results in Figure 1B 
were obtained by using the off-line immunoextraction of d-metham-
phetamine to aid in the measurement of this drug in urine by GC–
MS [14]. A related approach to immunoextraction is ‘immunodeple-
tion,’ in which an immobilized antibody column is used to selectively 
extract major components from a sample (e.g., major proteins), while 
other components (e.g., trace proteins) are allowed to pass through 
the column for further analysis [7,53].  
There are many examples of hybrid methods that have made use 
of immunoextraction [7–10,12,13]. For instance, immmunoextraction 
has been coupled with LC–MS for the measurement of S-metham-
phetamine in urine [45]. Immunoextraction columns have been used 
off-line with ultra-high performance LC (UHPLC) and MS/MS for the 
determination of aflatoxin M1 in ice cream [49], and immunoaffin-
ity columns were utilized off-line with LC–MS/MS for the analysis of 
multiple mycotoxins in food [50,51]. In addition, immunoextraction 
has been coupled both on-line and off-line with HPLC and fluores-
cence detection for the measurement of aflatoxins and mycotoxins 
in food [48,52,54], and used off-line with HPLC for the measurement 
of phenylethanolamine in animal feed and meat or liver samples [55]. 
Immobilized antibody fragments have been used to analyze the en-
antiomers of diarylalkyltriazole [56], and an immunoaffinity column 
has been used to separate ginsenoside epimers [57]. A chromato-
graphic immunoassay with direct detection was combined with re-
versed-phase LC for measuring the free fractions of warfarin enan-
tiomers in mixtures of this drug with HSA [58]. Immunoextraction has 
also been coupled with biointeraction analysis, as has been used to 
isolate and examine the binding of in vivo glycated HSA with sulfo-
nylurea drugs [59].  
Several applications have been reported for MIPs in the extraction 
of target compounds prior to their analysis by a second method. Ex-
amples include approaches that have been developed for the analysis 
of various herbicides and drugs in serum, urine, food or tissue sam-
ples [21,25]. A nano-sized MIP was prepared with multiple templates 
and used to extract various metabolites of polycyclic aromatic hydro-
carbons from urine, followed by the separation and measurement of 
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these compounds by UHPLC with fluorescence detection [60]. Mi-
crospheres based on MIPs were created and used for isolating clen-
buterol and other β-agonists from pork tissue, followed by their anal-
ysis using UHPLC coupled with MS/MS [61].  
 
 
Competitive binding chromatographic immunoassays  
 
A second group of chromatographic immunoassays are those that 
employ a competitive binding format. These methods are based on 
the indirect detection of a target through its competition with a la-
beled analog of the target (known as the ‘label’) for sites that are avail-
able in a column containing an antibody or related binding agent 
[8,10]. There are various types of competitive binding chromato-
graphic immunoassays. The three most common approaches are the 
simultaneous injection method, the sequential injection method and 
the displacement immunoassay [7,8,10].  
 
 
Simultaneous injection methods  
 
The simultaneous injection method is a type of competitive bind-
ing chromatographic immunoassay in which a sample is mixed with 
a fixed amount of the label and both are applied together to a col-
umn containing a limited amount of an immobilized antibody or re-
lated binding agent for the target (see Figure 4) [7,8,62,63]. The target 
and label compete for this binding agent as the sample/label mix-
ture is passed through the column. Once the nonretained portion of 
the mixture has been washed from the column, an elution buffer can 
be used to release the captured target and label. The amount of la-
bel that elutes either in the nonretained fraction or the retained peak 
can then be used for the indirect measurement of the amount of tar-
get that was in the original sample [7,8].  
The response of this method is dependent on many factors. These 
factors include the moles of label that are combined with the sample, 
the moles of the immobilized binding agent that are present, the in-
jection flow rate and the adsorption kinetics of the column [8,62]. It 
is also important to use a label which can produce a signal that will 
not be significantly affected by the presence of the sample matrix, if 
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the nonretained fraction is measured, or the elution buffer, if the re-
tained fraction is used for the analysis [8]. The lowest detection lim-
its in this method tend to occur at low-to-moderate flow rates and 
when using columns where the amount of active binding sites is in the 
same general range as the moles of target that are to be detected in 
the samples [8,62,63]. The fact that a labeled target analog is used in 
Figure 4. Chromatographic competitive binding immunoassay. (A) General scheme 
for a chromatographic-based competitive binding immunoassay using the simulta-
neous injection format and (B) a calibration curve obtained for gentamicin in this 
type of assay based on fluorescence detection and a 10 cm × 3 mm id antibody col-
umn. The labeled target analog, or ‘label,’ in (A) is represented by the stars and the 
target is represented by the hexagons. The plots in (B) were obtained from a set of 
two trials that were conducted after the initial development of the column (circles) 
and after 2 months (triangles).  (B) Adapted with permission from [66].   
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this method generally provides simultaneous injection methods with 
lower detection limits than can be obtained with chromatographic im-
munoassays that employ direct target detection [8].  
The simultaneous injection method has been used to measure 
many compounds, including both low and high mass targets, in 
complex samples [7,8,62–66]. This format has been used with ab-
sorbance measurements or fluorescent tags for the determination 
of proteins such as transferrin, IgG and HSA [8,62,63]. Other reports 
have used the simultaneous injection method with fluorescent la-
bels for analysis of the hormones testosterone, adrenocorticotropic 
hormone and cortisol [7,8]. This method has been employed for the 
measurement of cephalexin in milk [64], and the measurement of 
atrazine in water and citrus fruits [65]. The simultaneous injection 
method has also been used with a fluorescent label for measuring 
gentamicin in serum, as is illustrated in Figure 4B. In this last exam-
ple, results were obtained within 10 min, and the assay gave good 
agreement with an HPLC reference method [66]. A variation of the 
simultaneous injection method was reported for the analysis of Hg2+, 
in which an immobilized analog of the target (i.e., a protein–Hg2+ 
conjugate) was combined with both samples and antibodies that 
could bind to this metal ion [67].  
 
 
Sequential injection methods  
 
The sequential injection method is similar to the simultaneous in-
jection method but has the sample being applied first to a column 
containing an immobilized antibody or related binding agent, fol-
lowed later by application of the label [8,68]. The amount of label that 
elutes in either the nonretained or retained fractions is again used as 
an indirect measure of the amount of target that was in the sample 
[8]. The use of separate steps for the injection of the sample and la-
bel allows the target to have the first opportunity to bind to the im-
mobilized binding agent; this feature tends to result in lower limits of 
detection than can be obtained with the simultaneous injection for-
mat [62]. The use of separate application steps also creates a situa-
tion in which the label is never in contact with the sample. This ap-
proach helps to minimize or eliminate any effects the sample matrix 
may have on the measurement of the label [7,8,68].  
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Many of the same factors that affect the response of the simulta-
neous injection format affect the sequential injection method. For 
instance, the moles of the label and binding agent are important, in 
addition to the flow rate that is used for injection and the adsorp-
tion kinetics within the column [8,68]. The best limits of detection 
again tend to occur at low-to-moderate flow rates, but separate flow 
rates can now be utilized for the application of the sample and la-
bel [68]. Another difference between the simultaneous and sequen-
tial injection methods is in the effect of varying the amount of the 
label. In the simultaneous injection method, changing the amount 
of the label can have a relatively large effect on the limit of detec-
tion [8,62,63], while this effect is not as large in the sequential injec-
tion method [62,68].  
There have been many applications of the sequential injection 
method for measuring drugs, proteins and other targets [8,62,68–
72]. For instance, nonlabeled HSA was used as both the target and ‘la-
bel’ in an HPLC based sequential injection method that could measure 
this protein in samples in less than 10 min [68]. This general approach 
was used with an enzyme label and an antibody capillary column to 
measure hyaluronan in serum as a potential biomarker for liver dis-
ease and cancer [68]. The sequential injection method has also been 
utilized in bioprocess monitoring for the analysis of proteins such as 
IgG and HSA [8]. This method has been used with liposome labels and 
fluorescence detection for the measurement of IgE in serum [71]. It 
has further been employed with a label based on liposome-encapsu-
lated quantum dots in a multiplex assay for a variety of sulfonamides 
and quinoline residues in milk [72].  
 
 
Displacement immunoassays  
 
A displacement immunoassay is another form of a competitive 
binding chromatographic immunoassay [7,8,73]. In the most common 
format for this approach (see Figure 5), the label is first applied to a 
column containing an immobilized antibody or related agent and al-
lowed to occupy most or all of the binding sites in the column. The 
excess label is then washed away and the sample is injected. As the 
sample passes through the column, the target can bind to any sites 
that are momentarily unoccupied by the label. This competition results 
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in the displacement of some label and produces a peak for the dis-
placed label that is related to the amount of target that was in the 
sample [7,8].  
Figure 5. Chromatographic displacement immunoassay. (A) General scheme for a 
chromatographic-based displacement immunoassay and (B) a typical chromato-
gram obtained by this method for thyroxine (T4) when using acridinium ester-labeled 
triiodothyronine (AE-T3, which was the ‘label’ in this method) and anti-T4 antibodies 
that were adsorbed to a 10 mm × 2.1 mm id protein G column. The labeled target 
analog, or ‘label,’ in (A) is represented by the stars and the target is represented by 
the hexagons. In (B), the antibodies and label were combined and applied simul-
taneously to the protein G column; the displacement peak was monitored through 
the use of a postcolumn reactor to detect the chemiluminescence of the label. (B) 
Reproduced with permission from [30].  
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There are several potential advantages to this approach when 
compared with other types of competitive binding immunoas-
says. First, the response due to the displaced label increases as the 
amount of the target is increased, and often does so in a linear 
manner at low-to-moderate target concentrations [7,8]. Second, the 
displacement peak often appears with or just after the nonretained 
sample components, which can lead to a method with short anal-
ysis times [8,27,30]. Third, this method can be utilized for relatively 
high throughput measurements, especially if the amount of label 
that is present in the column is sufficient for use with multiple sam-
ple injections before the column must be regenerated and reloaded 
with the label [7,8,27,30,73]. Like the simultaneous and sequential 
injection methods, a displacement immunoassay can often be used 
to obtain lower limits of detection than can be acquired with chro-
matographic immunoassays that employ direct detection. The main 
disadvantage of all these competitive binding immunoassays when 
compared with direct detection is that they require a labeled analog 
of the target [7,8].  
Several factors can affect the behavior of a displacement assay. 
These factors include the amount and type of label that is used, the in-
jection flow rate and the application conditions that are employed for 
the label and the sample, the amount of binding agent that is in the 
column, and the association/dissociation rates of the binding agent 
for the target and label [8]. For instance, the injection flow rate must 
be slow enough to provide sufficient time for the target to bind to the 
column and displace enough label to give a measurable response. This 
method also requires that the label dissociates from the antibodies at 
a rate that is neither too fast nor too slow. A fast rate of label dissoci-
ation will result in a high signal for the first few sample injections, but 
this signal will quickly decrease for later sample injections as the la-
bel leaves the column. On the other hand, a slow rate of label disso-
ciation will lead to broad displacement peaks that may be difficult to 
detect [8]. Another consideration is the binding constant for the la-
bel with the immobilized antibodies or binding agents. Best displace-
ment results tend to be obtained when the label has a binding con-
stant that is not as strong as it is for the target [8,30].  
A variety of applications have been reported for displacement 
immunoassays [7,27,30,74,75]. One recent application has been 
the use of this format in combination with ultrafast immunoaffinity 
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extraction for the analysis of free drug or free hormone fractions in 
serum or in mixtures of these agents with transport proteins [27,30]. 
An example of such an application, which was combined with che-
miluminescent detection to measure the free fraction of thyroxine in 
serum, is illustrated in Figure 5B. This technique gave a result within 
30 s of sample injection and had a detection limit of 6 pM [30]. Dis-
placement immunoassays have also been used to detect drugs such 
as cocaine or benzoylecgonine and targets such as coumaphos or 
ochratoxins [7,74,75].  
 
 
Immunometric assays  
 
Chromatographic immunoassays can also be carried out by using 
various immunometric formats [7,8,10–12]. These methods are non-
competitive immunoassays that utilize indirect detection and a la-
beled antibody or labeled binding agent to measure a target [5]. The 
two primary formats for these assays, when used in chromatographic 
systems, are sandwich immunoassays (i.e., two-site immunometric as-
says) and one-site immunometric assays [7,8].  
 
 
Sandwich immunoassays  
 
A chromatographic sandwich immunoassay employs two types of 
antibodies or related binding agents that can bind simultaneously to 
the same target [3,8,10]. Figure 6 shows one way in which this type of 
assay can be carried out in a chromatographic system. In this exam-
ple, one type of antibody or binding agent is immobilized to a sup-
port and placed within the column. The other antibody/binding agent 
is labeled and mixed with the sample before both of these compo-
nents are applied to the column or applied to the column after the 
sample has been injected [29]. The result is the formation of a sand-
wich complex in which the target is bound to both a labeled binding 
agent and an immobilized binding agent. The retained target and its 
associated labeled binding agent can later be eluted from the column. 
The amount of retained labeled binding agent is then measured and 
used to provide a response that is related to the amount of target that 
was in the original sample. If desired, the column or support may then 
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Figure 6. Chromatographic sandwich immunoassay. (A) General scheme for a chro-
matographic-based sandwich immunoassay and (B) a set of chromatograms ob-
tained for the detection of PTH in plasma by using a 20 mm × 4 mm id column con-
taining immobilized antibodies that could bind to one region of PTH, along with 
soluble acridinium ester-labeled antibodies against a different region of PTH to form 
a sandwich complex with this target. The tag on the soluble and labeled antibod-
ies in (A) is represented by the stars and the target is represented by the hexagons. 
A postcolumn reactor was used in (B) to detect the chemiluminescence of the la-
beled antibodies that were retained by the column; sample injections were made 
every 6 min, as indicated by the arrows. Both the response due to the nonretained 
sample components, as measured at 280 nm, and the chemiluminescent response 
measured for samples containing (from left-to-right) 0, 25, 50 or 75 pM PTH are 
shown in (B).  PTH: Parathyroid hormone.  (B) Adapted with permission from [29]. 
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be regenerated and used for the next application of the sample and 
labeled binding agent [8,10].  
One advantage of using a chromatographic sandwich immunoas-
say, especially when compared with simultaneous and sequential in-
jection competitive binding immunoassays, is that it can give a linear 
response over a relatively broad range of target concentrations [8]. 
This response, plus the selectivity that is provided by using two types 
of binding agents for the same target, can result in better selectivity 
and lower limits of detection than can usually be obtained in compet-
itive binding assays or direct detection methods [3,7,8,12]. A limitation 
of sandwich immunoassays is that they can only be used with rela-
tively high mass targets such as proteins, large peptides or other mac-
romolecules that can interact with two antibodies/binding agents si-
multaneously. The need for two types of binding agents can also make 
this approach more expensive than a competitive binding assay [8].  
Several types of targets have been examined by using chromato-
graphic-based sandwich immunoassays [7,8]. For instance, chro-
matographic sandwich immunoassays using chemiluminescent tags 
or enzyme labels have been developed for human and mouse IgG 
[7,8,76,77]. Related methods using fluorescence or amperomet-
ric detection have been utilized for the measurement of HSA [7,78]. 
A system based on this format has been developed for analysis of 
parathyroid hormone in plasma by using chemiluminescent labeled 
antibodies, with results being obtained within 6 min of sample injec-
tion [29], as shown in Figure 6B. Another method combined chemi-
luminescent detection with traditional antibodies or nanobodies that 
were attached to magnetic beads and silica nanoparticles for use in 
flow-based sandwich immunoassays that could measure microcystin-
LR or prealbumin [79,80]. Other chromatographic sandwich immu-
noassays have been described for IL-5, anti-HCV antibodies, potato 
virus X, cardiac troponin and myoglobin [81–84]. Sandwich immuno-
assays have also been applied to the determination of allergens, bac-
teria and toxins in food [85–89].  
Chromatographic sandwich immunoassays have been developed 
for other applications. This type of assay was utilized for examin-
ing a lipopolysaccharide antigen and cells of Brucella abortus [90]. 
A method for measuring hepatitis B virus surface antigen in serum 
was created by using a chromatographic sandwich immunoassay with 
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fluorescence detection [91]. A test strip utilizing this general approach 
was developed for the detection of rabies in canine serum [92]. Quan-
tum dots were employed in a sandwich immunoassay format for the 
analysis of C-reactive protein [93], and chromatographic sandwich im-
munoassays have been made for detecting lily mottle virus and lily 
symptomless virus [94,95]. In addition, sandwich immunoassays in a 
chromatographic format have been employed with gold nanoparti-
cle labels for the diagnosis of malaria and for the detection of S. au-
reus [96,97]. Aptamers have also been utilized in sandwich immuno-
assays on planar supports [98–100]. For instance, a flow-based sensor 
for thrombin was created that used immobilized aptamers and ap-
tamers that were conjugated to gold nanoparticles for detection [98]. 
Similar approaches using aptamers have been reported for Ramos 
cells [99] and E. coli [100].  
 
 
One-site immunometric assays  
 
One-site immunometric assays can also be carried out in a chro-
matographic format [8]. This method first involves the incubation of 
a sample containing the target with an excess of labeled antibodies, 
or related binding agents like antibody fragments that can bind this 
target (see Figure 7). This mixture is then injected onto a column that 
contains an immobilized analog of the target. The target and its com-
plex with the labeled antibody/binding agent will tend to pass through 
the column, while the immobilized analog will capture any excess of 
the labeled binding agent that is still present. The size of the nonre-
tained peak due to the complex of the target with the labeled agent 
provides a response that is related to the amount of target that was 
in the sample. An elution buffer can later be passed through the col-
umn to release the captured and labeled binding agent; the size of 
this retained peak can also be used to determine how much target 
was present in the sample. If desired, the column can be regenerated 
before making another series of injections of the target and labeled 
binding agent [101,102].  
A linear increase in response over a relatively broad range of tar-
get levels can be obtained when using the nonretained peak due to 
the labeled binding agent and its complex with the target [8,102]. 
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Figure 7. Chromatographic one-site immunometric assay. (A) General scheme for 
a chromatographic-based onesite immunometric assay and (B) calibration plots 
obtained in this method by using anti-HSA antibodies that were labeled with a NIR 
fluorescent tag and injected with samples onto a 5 mm × 2.1 mm id microcolumn 
containing immobilized HSA. The tag on the soluble and labeled antibodies in (A) 
is represented by the stars, the target is represented by the hexagons in solution 
and the immobilized target analog is represented by the hexagons at the surface 
of the support. The error bars in (B) represent a range of ± 1 standard error of the 
mean (n = 3). HSA: Human serum albumin; NIR: Near-infrared.  (B) Reproduced 
with permission from [26].   
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Alternatively, a decrease in response with the target’s concentration is 
seen if the retained fraction of the labeled binding agent is used [8]. 
The response of this method will be affected by the amount of the la-
beled binding agent that is combined with the sample, the time that is 
allowed for the incubation step, the binding capacity of the immobi-
lized analog column and the capture efficiency of the column for the 
labeled binding agent [8,102]. One advantage of this method when 
compared with other chromatographic immunoassays is that if the 
column binding capacity is sufficiently high, multiple sample/labeled 
binding agent mixtures can be injected between elution/regeneration 
cycles. Another advantage of using an immobilized analog column is 
that elution conditions can be used that may not be feasible in tech-
niques that instead employ immobilized antibodies or antibody frag-
ments (e.g., competitive binding immunoassays or sandwich immu-
noassays) [8,102]. The main limitation of this format is the need for a 
different immobilized analog column for each target or group of tar-
gets that are to be analyzed [8].  
One-site immunometric assays have been described for drugs, hor-
mones, proteins and other targets [26,101– 106]. An example is pro-
vided in Figure 7B, in which this format was used with affinity micro-
columns and fluorescence or near-infrared fluorescence detection for 
the trace analysis of a protein (HSA), giving results within 35 s to 2.8 
min of sample injection [26]. This format has also been used with flu-
orescence detection for the analysis of granulocyte-colony stimulat-
ing factor, modified with poly(ethylene glycol), in rat serum [103] and 
IL-10 in cell media [104]. This approach has been utilized with enzyme 
labels to detect digoxin or digoxigenin [105], with chemiluminescence 
detection for the measurement of thyroxine [102], and with a lipo-
some label to monitor 17-beta-estradiol [106]. Several of these meth-
ods have further been used in postcolumn reactors for the detection 
of targets as they are separated by other chromatographic methods, 
such as reversed-phase LC [7,101,103].  
 
 
Conclusion  
 
This review examined the general principles of chromatographic 
immunoassays and the use of these methods for the analysis of drugs, 
biological compounds and other targets in complex samples. The 
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main components of a chromatographic immunoassay were dis-
cussed, including the types of binding agents, detection methods 
and supports that have been used in these techniques. The various 
formats that can be used in a chromatographic immunoassay were 
then examined. This included a brief discussion of the advantages or 
limitations of each method and the factors that affect their response. 
Recent research and developments in this area were discussed, and a 
variety of applications for chromatographic immunoassays were pre-
sented. These applications ranged from small targets such as drugs, 
hormones and environmental agents to larger targets such as pep-
tides, proteins, viral particles, bacteria and cells.  
 
 
Future perspective  
 
The current field of chromatographic immunoassays already en-
compasses a relatively broad range of assay formats and applications. 
It is expected that the types of components that can be used in these 
methods and the formats in which they can be employed will con-
tinue to undergo development. One possible area of future research 
is in the types of binding agents that can be used in chromatographic 
immunoassays and related methods. This is expected to include the 
more extensive use of aptamers [17–20] and MIPs [21–25,46,47] as al-
ternatives to antibodies. It is also anticipated that there will be more 
applications in chromatographic immunoassays that make use of 
binding agents such as bispecific antibodies, single-chain antibody 
fragments and ‘nanobodies’ [6,16,80,107]. The use of other synthetic 
mimics of antibodies (or ‘synbodies’) [108] is another area for possi-
ble growth in this field.  
Other work that is expected to continue in chromatographic im-
munoassays is in the types of detection methods, supports and assay 
formats that can be used in these techniques. For example, the use 
of nanomaterials, such as gold or silver nanoparticles, and quantum 
dots should continue to lead to new or enhanced detection meth-
ods and formats for these methods [19,85–88,93– 100,109]. The uti-
lization of alternative supports, such as affinity monoliths, is also 
expected to continue [110–116]. In addition, further research is antic-
ipated in the development of miniaturized chromatographic immu-
noassays that can be employed in microfluidic devices and portable 
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or disposable devices [19,26–28,30,82–88,100,113,116]. These de-
velopments, in turn, should increase the range of applications for 
which chromatographic immunoassays can be used in areas that in-
clude clinical chemistry, pharmaceutical testing, drug development 
and biomedical research [7,8].  
 
Executive summary  
Background  
• Chromatographic immunoassays use an antibody or related binding agent as 
part of a chromatographic system for the isolation or measurement of a spe-
cific target.  
General components of chromatographic immunoassays  
• Polyclonal or monoclonal antibodies are often used in these methods, along 
with antibody fragments; other binding agents that have been employed in-
clude autoantibodies, anti-idiotypic antibodies, genetically engineered anti-
bodies or antibody fragments, aptamers and molecularly imprinted polymers. 
• A wide range of detection methods have been used in chromatographic immu-
noassays, such as absorbance or fluorescence detection, chemiluminescence, 
electrochemical detection, radiometric detection, thermal measurements and 
MS, as well as methods that use enzymes or liposomes as labels.  
• Various support materials and immobilization schemes can be used in chro-
matographic immunoassays, along with formats based on columns or pla-
nar supports.  
Chromatographic immunoassays with direct target detection  
• Some chromatographic immunoassays can be used for the direct detection of a 
target, as may involve detection based on light absorption, fluorescence, che-
miluminescence or MS.  
• It is also possible to use the immunoextraction of a target prior to its measure-
ment or analysis by a second method, such as HPLC, ultra-high performance 
LC, LC–MS or LC–MS/MS.  
Competitive binding chromatographic immunoassays  
• Competitive binding immunoassays can be carried out in a chromatographic 
immunoassay by using simultaneous or sequential injection of the sample and 
a labeled analog of the target.  
• A displacement immunoassay format is another form of a competitive binding 
immunoassay that can be carried out in a flow-based system.  
Immunometric assays  
• Labeled antibodies or binding agents can also be used in chromatographic im-
munoassays, resulting in methods that are known as immunometric assays.  
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• The two common forms of chromatographic-based immunometric assays are 
sandwich immunoassays and one-site immunometric assays.  
Conclusion  
• Chromatographic immunoassays have been used for the selective analysis of 
drugs, hormones, peptides, proteins and other agents in areas that include 
clinical chemistry, pharmaceutical analysis, biomedical research and food 
testing.   
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